Intelligencia
intelligencia.ai
Predictive Analytics
Drug Discovery AI
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$13.8M
1 round on record
Latest round
$13.8M
Venture round · Aug 2021 · 5 yr ago
Team
51-200
employees, estimated range
Backers
2
Big Pi Ventures, MTIP
The money's age
Long since its last round
62 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 12
Recognition Intelligencia AI Named to the Inc. 5000 2026 List of America's Fastest-Growing Private Companies · intelligencia.ai
Mar 20, 2024
Recognition Intelligencia AI Ranks No. 90 on Inc. Magazine's List of the Northeast Region's Fastest-Growing Private Companies · YahooFinance
Aug 6, 2021
Raised a round Venture round $13.8M · SEC Form D
2017
Founded
Tractionpublic signals, read monthly
Web presence
top 0.13%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2021 | $13.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Intelligencia Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Evangelos VergetisExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Big Pi Ventures 
MTIP Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
InterGen Data uses predictive analytics to forecast life events empowering financial professionals, insurers, and healthcare providers with…
Empowering healthcare professionals with AI-driven software to automate scheduling, enhance decision-making, and ensure safer staffing…
Weave Bio is the AI platform built for drug development — automating regulatory submissions, IND filings, and HAQ management. Based in San…
About Us At GEOLYTIX we help our customers make informed decisions about how many stores, who to acquire, where to open, which format, how…
Predict the outcome of your next case. Theo Ai uses predictive analytics to deliver clarity and confidence in every legal decision.
AI-powered gene expression models predict human tissue responses to drugs. De-risk clinical trials, optimize patient selection, and…
News
MI és a világvége: Miért hiszik egyes keresztények, hogy a mesterséges intelligencia az antikrisztus?
A TikTok-videóktól és podcastoktól kezdve a könyvekig sok keresztény vallja, hogy a mesterséges intelligencia az antikrisztus eszköze, vagy akár maga az antikrisztus. De mit gondolnak erről a vallási szakértők?
Read more
Report
Súlyos veszélyre figyelmeztet a pápa: az embertelenedés kockázatát hozza el a mesterséges intelligencia
Kritikusan kell kell kezelni szerinte.
Read more
Report
The Insight Drop From Control to Reset: Autoimmune R&D Is Changing the Endgame
TL;DR Immune reset is rapidly gaining momentum in autoimmune R&D, moving beyond chronic immunomodulation toward finite treatment and potential durable remission. Immune-reset programs grew from 8 in 2022 to 149 in 2025, overtaking chronic immunomodulation
Read more
Report
From Conviction to Evidence: A Conversation with a Senior Director of Search & Evaluation
TL;DR Faster deal timelines demand faster, more defensible decisions. Intelligencia helped the team challenge internal bias and distinguish true opportunity from high-failure areas. Transparent, granular evidence gave the team greater confidence in asset
Read more
Report
The Insight Drop When AI Sounds Right: The Hidden Risk in Pharma R&D
TL;DR AI can sound right without being complete. As pharma R&D questions become more complex, Truth declines faster than Trust. Better models and better data help, but structured pharmaceutical knowledge is critical for reliable AI-driven analysis. Large
Read more
Report
AI in Pharma: Why Information Matters More Than Models
By Andreas Dimakakos, Director of Scientific Insights; Kate Smietana, Director, Knowledge & Thought Leadership; Sofia Mastoraki, Senior Customer Experience & Insights Associate, Panos Karelis, VP of Commercial; and Dimitris Skaltsas, Co-founder & CEO TL;D
Read more
Report
Intelligencia AI Named to the Inc. 5000 2026 List of America's Fastest-Growing Private Companies
Intelligencia AI is proud to announce its inclusion on the 2026 Inc. 5000 list for the third consecutive year, ranking among America's fastest-growing private companies. The company was also recognized within the Artificial Intelligence and Data industry,
Read more
Report
The Insight Drop B7-H3 (CD276): The ADC Race to Unlock a High-Momentum Target
(How a 20-year-old target became a 2021-onward surge, why early modalities stalled, and what it will take to convert momentum into approvals) TL;DR B7-H3 has moved from a long-standing biological hypothesis to a high-momentum clinical target, with the sur
Read more
Report
Intelligencia AI - Industry Partners Boston Roundtable
We will be hosting an executive roundtable in Boston with industry leaders to discuss the evolving challenges of clinical development.It will be a great opportunity to exchange perspectives, explore emerging trends, and hear firsthand how teams across the
Read more
Report
Clinical Success Is No Longer One Number
By Andreas Dimakakos, Director of Clinical Data; Kate Smietana, Director, Knowledge and Thought Leadership; Panos Karelis, VP of Commercial; and Dimitris Skaltsas, Co-founder & CEO TL;DR Traditional drug development benchmarks measure overall success rate
Read more
Report
Show more news
People
Evangelos Vergetis
Executive Officer, Director
Dimitrios Skaltsas
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
2
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Financials
Total raised
$13.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2021 | $13.8M | Details |